復星醫藥(600196.SH):復星醫療與星雙健、復星健控擬按持股比例對卓瑞門診進行增資
格隆匯 8 月 14日丨復星醫藥(600196.SH)公佈,2020年8月14日,公司控股子公司上海復星醫療(集團)有限公司(“復星醫療”)、卓瑞門診與關聯方星雙健、復星健控簽訂《增資協議》,復星醫療與星雙健、復星健控擬根據各自所持卓瑞門診股權比例合計出資人民幣2000萬元對卓瑞門診進行增資,其中:復星醫療擬出資人民幣1020萬元認繳卓瑞門診新增註冊資本人民幣1020萬元;星雙健、復星健控擬分別出資人民幣490萬元、490萬元認繳卓瑞門診新增註冊資本人民幣490萬元、490萬元。
此次交易完成後,卓瑞門診的註冊資本將由人民幣4700萬元增至人民幣6700萬元,其中:復星醫療仍將持有卓瑞門診51%的股權;卓瑞門診仍為公司控股子公司。
卓瑞門診系營利性醫療機構,主要通過引進國內外優質醫療資源,提供體檢、全科、專科門診等醫療服務。此次增資款項將主要用於卓瑞門診的日常運營以及配置醫療設備等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.